| PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing. (NCT06036225) | Belfast Health and Social Care Trust | 2022-07-24 |
| Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN) (NCT05275907) | Northwestern University | 2022-07-12 |
| Ex-vivo Hypotermic Perfusion in Patients With Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurrence (NCT06720675) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2022-06-03 |
| NRP vs DHOPE vs COR-NMP in ECD-DCD Donation (NCT05327478) | Erasmus Medical Center | 2022-01-01 |
| Patients With Diabetes Mellitus on Drug Treatment on the List or Already Undergoing Orthotopic Liver Transplantation (NCT06816303) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2021-11-19 |
| US National OCS Liver Perfusion (OLP) Registry (NCT05940857) | TransMedics | 2021-10-14 |
| OCS Liver Perfusion (OLP) Post-Approval Registry (NCT05074160) | TransMedics | 2021-10-14 |
| Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation (NCT05087550) | Methodist Health System | 2021-10-13 |
| Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation (NCT05051605) | Ain Shams University | 2021-09-15 |
| PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCC (NCT04792801) | University Hospital, Lille | 2021-06-22 |
| Observational Study of Eating Behavior in Patients With Diabetes Mellitus and Obesity Undergoing Liver Transplantation (NCT06714786) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2021-04-30 |
| Liver Transplantation With Tregs at UCSF (NCT03654040) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-04-22 |
| Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients (NCT04867720) | Chong Kun Dang Pharmaceutical | 2021-03-16 |
| Early Nutritional Intervention in Patients Undergoing Liver Transplantation (NCT07168369) | Centre hospitalier de l'Université de Montréal (CHUM) | 2021-02-15 |
| Early Versus Routine Drain Removal After Live Liver Donor Hepatectomy (NCT04504487) | Institute of Liver and Biliary Sciences, India | 2021-01-28 |
| Liver Transplantation and Coronavirus Disease 2019 (COVID-19) (NCT04695756) | Hospital Italiano de Buenos Aires | 2020-12-15 |
| Utilization of Donor Whole Blood for Blood Transfusion in Deceased Donor Liver Transplantation (NCT04383756) | Vanderbilt University Medical Center | 2020-12-01 |
| LIFT Intervention in Liver Transplant Candidates (NCT04836923) | Northwestern University | 2020-10-01 |
| Cabozantinib to Treat Recurrent Liver Cancer Post Transplant (NCT04204850) | University Health Network, Toronto | 2020-08-07 |
| OCS Liver DCD Trial (NCT04194437) | TransMedics | 2020-07-24 |
| Quantra QStat in Trauma and Liver Transplant (NCT04312958) | HemoSonics LLC | 2020-07-20 |
| Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients. (NCT04471441) | Chong Kun Dang Pharmaceutical | 2020-06-30 |
| A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Liver Transplant Recipients (NCT03515330) | Johns Hopkins University | 2020-06-29 |
| Hepato-duodenal Ligament Occlusion and Classic Technique in Liver Transplant (NCT04265157) | Assiut University | 2020-03-01 |
| OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study (NCT05096754) | TransMedics | 2020-02-03 |
| OCS Liver PROTECT Continued Access Protocol (NCT04186221) | TransMedics | 2020-02-03 |
| MicroRNA Profile As a Biomarker of Liver Damage in Different Types of Liver Donors. (NCT06611046) | Mar Dalmau | 2019-10-02 |
| The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients (NCT03819322) | Fernanda P Silveira, MD, MS | 2019-08-15 |
| Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL) (NCT04069065) | Chong Kun Dang Pharmaceutical | 2019-07-31 |
| Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver Transplant (NCT04035876) | Zhejiang University | 2019-07-16 |
| Controlled Donors After Circulatory Death and Brain Death: a Multicenter Study of Transfusion, One-year Graft Survival and Mortality. Cohort Study, (NCT04945135) | Hospital Clinic of Barcelona | 2019-06-01 |
| Microbiota Study in Liver Transplanted Patients (NCT03507140) | University Hospital, Grenoble | 2019-04-16 |
| Outflow Reconstruction in Right Lobe Living Donor Liver Transplantation (NCT03666689) | Assiut University | 2018-10-01 |
| Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine (NCT03527238) | University of Florida | 2018-09-21 |
| Stented Biliary Anastomosis in Living Donor Liver Transplantation (NCT03636321) | Alaa Mstafa Hassan Sewefy | 2018-08-10 |
| Copeptin Serum Level in Liver Transplant Recipients (NCT03587623) | Medical University of Warsaw | 2018-07-04 |
| Individualized Multimodal Hemostasis Evaluation Pyramid (IMHOTEP) (NCT03555383) | Semmelweis University | 2017-08-01 |
| HOPE for Human Extended Criteria and Donation After Brain Death Donor (ECD-DBD) Liver Allografts (NCT03124641) | University Hospital, Aachen | 2017-01-17 |
| Controlled Attenuation Parameter (CAP) in Liver Allografts (NCT02798861) | Andres Duarte-Rojo | 2016-09-07 |
| Eating Behavior, Food Craving and Relation to Excessive Weight Gain in Patients Submitted to Liver Transplantation (NCT03411616) | Federal University of Minas Gerais | 2016-08-23 |
| A Cohort Study of Operationally Tolerant Allograft Recipients (NCT02743793) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-06-30 |
| A Physical Activity Program in End-state Liver Disease (NCT02776553) | University of Arkansas | 2016-06-01 |
| Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant (NCT02429869) | University of California, San Francisco | 2016-02-24 |
| Interest of the Donor-specific Antibodies After Liver Transplantation (NCT03238443) | University Hospital, Lille | 2016-02-16 |
| OCS Liver PROTECT Continuation Post-Approval Study (NCT05096741) | TransMedics | 2016-01-24 |
| Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation (NCT02533180) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-12-15 |
| Eating Behaviour and Gustatory Sensitivity Before and After Liver Transplant in Cirrhotic Patients (NCT02859506) | Centre Hospitalier Universitaire Dijon | 2015-07-03 |
| Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood (NCT02718573) | Icahn School of Medicine at Mount Sinai | 2015-01-01 |
| Ischemia Time and Graft Survival (NCT02521584) | AlRefaey Kandeel | 2015-01-01 |
| Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (NCT02182986) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-08-14 |
| A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant (NCT02057484) | Astellas Pharma Europe Ltd. | 2014-03-03 |
| Increasing Activity in Liver Transplant Patients (NCT02058498) | Mayo Clinic | 2014-02-01 |
| A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients. (NCT02040584) | Novartis Pharmaceuticals | 2013-12-20 |
| Cardiac Functions in Living Donor Liver Transplant Recipients. An Echocardiographic Study. (NCT01840514) | Mansoura University | 2012-12-01 |
| Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients. (NCT01598987) | Novartis Pharmaceuticals | 2012-10-01 |
| Text Messaging for Adherence in Adolescent Liver Transplant Recipients (NCT01696331) | Stanford University | 2012-09-01 |
| Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation (NCT01230502) | University of Wisconsin, Madison | 2011-11-01 |
| Australian and New Zealand Massive Transfusion Registry (NCT02863250) | Monash University | 2011-03-01 |
| Recurrence of Hereditary Hemorrhagic Telangiectasia (HHT) After Liver Transplantation (NCT03942315) | Hospices Civils de Lyon | 2011-01-01 |
| Home-Care Needs in Liver or Renal Transplantation Recipients and Their Spouses (NCT01380002) | National Taiwan University Hospital | 2010-12-01 |
| Closed-loop Anaesthesia for Liver Transplantation: a Pilot Study (NCT03357900) | Hopital Foch | 2010-08-18 |
| Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts (NCT01172691) | Baylor Research Institute | 2010-07-01 |
| Proteogenomic Monitoring and Assessment of Liver Transplant Recipients (NCT01644903) | Northwestern University | 2010-04-01 |
| Albumin, Total and Free Fraction of Mycophenolic Acid, and Measurement of IMPDH Activity in Liver Transplants. (NCT00995956) | Oslo University Hospital | 2010-01-01 |
| Intraoperative Glucose Control in Liver Transplant (NCT00780026) | University of Michigan | 2008-07-01 |
| Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant Recipients (NCT01884038) | United Therapeutics | 2008-06-01 |
| Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients (NCT00698399) | Vanderbilt University Medical Center | 2008-03-01 |
| Systemic Variables in the Saliva of Children Undergoing Liver Transplantation (NCT01307163) | Hadassah Medical Organization | 2008-01-01 |
| An Assessment of Voriconazole Pharmacokinetics and Pharmacogenetics in Liver Transplant Recipients - Pilot Study (NCT00371605) | University of Pittsburgh | 2006-12-01 |
| Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients (NCT00320606) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-05 |
| Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus (NCT00260208) | Novartis Pharmaceuticals | 2006-01-01 |
| Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C (NCT00275548) | Mayo Clinic | 2004-07-01 |
| Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients (NCT00171509) | Novartis | 2004-05-01 |
| Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients (NCT00171743) | Novartis | 2004-04-01 |
| Pediatric Liver Database (NCT00677625) | Medical College of Wisconsin | 2003-06-01 |
| Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantation (NCT00238901) | Novartis | 2002-12-01 |
| Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients (NCT00149994) | Novartis Pharmaceuticals | 2002-12-01 |